112 related articles for article (PubMed ID: 8282534)
1. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on responses to lipopolysaccharide (LPS) by isolated murine B-cells.
Morris DL; Karras JG; Holsapple MP
Immunopharmacology; 1993; 26(2):105-12. PubMed ID: 8282534
[TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
Sulentic CE; Holsapple MP; Kaminski NE
Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
[TBL] [Abstract][Full Text] [Related]
3. Characterization of protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine lymphocytes: indirect evidence for a role in the suppression of humoral immunity.
Snyder NK; Kramer CM; Dooley RK; Holsapple MP
Drug Chem Toxicol; 1993; 16(2):135-63. PubMed ID: 8486096
[TBL] [Abstract][Full Text] [Related]
4. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.
Karras JG; Morris DL; Matulka RA; Kramer CM; Holsapple MP
Toxicol Appl Pharmacol; 1996 Apr; 137(2):275-84. PubMed ID: 8661353
[TBL] [Abstract][Full Text] [Related]
5. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation.
Luster MI; Germolec DR; Clark G; Wiegand G; Rosenthal GJ
J Immunol; 1988 Feb; 140(3):928-35. PubMed ID: 3257509
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Karras JG; Holsapple MP
Toxicol Appl Pharmacol; 1994 Apr; 125(2):264-70. PubMed ID: 8171434
[TBL] [Abstract][Full Text] [Related]
7. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells.
Crawford RB; Sulentic CE; Yoo BS; Kaminski NE
Toxicol Sci; 2003 Oct; 75(2):333-42. PubMed ID: 12883080
[TBL] [Abstract][Full Text] [Related]
8. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity: II. B cell activation.
Morris DL; Holsapple MP
Immunopharmacology; 1991; 21(3):171-81. PubMed ID: 1917439
[TBL] [Abstract][Full Text] [Related]
9. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsillar lymphocytes.
Wood SC; Jeong HG; Morris DL; Holsapple MP
Toxicology; 1993 Jul; 81(2):131-43. PubMed ID: 8378939
[TBL] [Abstract][Full Text] [Related]
10. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
[TBL] [Abstract][Full Text] [Related]
11. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on interleukin-4-mediated mechanisms of immunity.
Karras JG; Conrad DH; Holsapple MP
Toxicol Lett; 1995 Jan; 75(1-3):225-33. PubMed ID: 7863531
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
[TBL] [Abstract][Full Text] [Related]
13. Direct suppression of antibody responses by chlorinated dibenzodioxins in cultured spleen cells from (C57BL/6 x C3H)F1 and DBA/2 mice.
Holsapple MP; Dooley RK; McNerney PJ; McCay JA
Immunopharmacology; 1986 Dec; 12(3):175-86. PubMed ID: 3818259
[TBL] [Abstract][Full Text] [Related]
14. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
[TBL] [Abstract][Full Text] [Related]
15. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells.
Yoo BS; Boverhof DR; Shnaider D; Crawford RB; Zacharewski TR; Kaminski NE
Toxicol Sci; 2004 Feb; 77(2):272-9. PubMed ID: 14600275
[TBL] [Abstract][Full Text] [Related]
16. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.
North CM; Crawford RB; Lu H; Kaminski NE
Toxicol Sci; 2010 Jul; 116(1):99-112. PubMed ID: 20348231
[TBL] [Abstract][Full Text] [Related]
17. Changes in DNA methylation and gene expression during 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced suppression of the lipopolysaccharide-stimulated IgM response in splenocytes.
McClure EA; North CM; Kaminski NE; Goodman JI
Toxicol Sci; 2011 Apr; 120(2):339-48. PubMed ID: 21212295
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: II. The role of the T-lymphocyte.
Dooley RK; Morris DL; Holsapple MP
Immunopharmacology; 1990; 19(1):47-58. PubMed ID: 2307581
[TBL] [Abstract][Full Text] [Related]
19. Direct suppression of superantigen-induced IgM secretion in human lymphocytes by 2,3,7,8-TCDD.
Wood SC; Holsapple MP
Toxicol Appl Pharmacol; 1993 Oct; 122(2):308-13. PubMed ID: 8212013
[TBL] [Abstract][Full Text] [Related]
20. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on T cell-derived cytokine production in ovalbumin (OVA)-immunized C57Bl/6 mice.
Nohara K; Fujimaki H; Tsukumo Si; Inouye K; Sone H; Tohyama C
Toxicology; 2002 Mar; 172(1):49-58. PubMed ID: 11844614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
